Global Oncology Biosimilars Market Survey and Trend Research 2018
SUMMARY
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Oncology Biosimilars Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 ONCOLOGY BIOSIMILARS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
PART 4 KEY COMPANIES LIST
4.1 Celltrion Inc. (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Pfizer Inc. (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Biocon (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 BIOCAD (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Dr. Reddy's (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Dr. Reddy's (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Sandoz International GmbH (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Intas Pharmaceuticals Ltd. (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 STADA Arzneimittel AG (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Teva Pharmaceutical Industries Ltd (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Oncology Biosimilars Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 ONCOLOGY BIOSIMILARS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
PART 4 KEY COMPANIES LIST
4.1 Celltrion Inc. (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Pfizer Inc. (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Biocon (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 BIOCAD (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Dr. Reddy's (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Dr. Reddy's (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Sandoz International GmbH (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Intas Pharmaceuticals Ltd. (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 STADA Arzneimittel AG (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Teva Pharmaceutical Industries Ltd (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global Oncology Biosimilars Market 2012-2017, by Type, in USD Million
Table Global Oncology Biosimilars Market 2012-2017, by Type, in Volume
Table Global Oncology Biosimilars Market Forecast 2018-2023, by Type, in USD Million
Table Global Oncology Biosimilars Market Forecast 2018-2023, by Type, in Volume
Table Celltrion Inc. Overview List
Table Oncology Biosimilars Business Operation of Celltrion Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Oncology Biosimilars Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Oncology Biosimilars Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BIOCAD Overview List
Table Oncology Biosimilars Business Operation of BIOCAD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Overview List
Table Oncology Biosimilars Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Overview List
Table Oncology Biosimilars Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz International GmbH Overview List
Table Oncology Biosimilars Business Operation of Sandoz International GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Ltd. Overview List
Table Oncology Biosimilars Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table STADA Arzneimittel AG Overview List
Table Oncology Biosimilars Business Operation of STADA Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Oncology Biosimilars Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Oncology Biosimilars Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Oncology Biosimilars Sales Revenue Share, by Companies, in USD Million
Table Global Oncology Biosimilars Sales Volume 2012-2017, by Companies, in Volume
Table Global Oncology Biosimilars Sales Revenue Share, by Companies in 2017, in Volume
Table Oncology Biosimilars Demand 2012-2017, by Application, in USD Million
Table Oncology Biosimilars Demand 2012-2017, by Application, in Volume
Table Oncology Biosimilars Demand Forecast 2018-2023, by Application, in USD Million
Table Oncology Biosimilars Demand Forecast 2018-2023, by Application, in Volume
Table Global Oncology Biosimilars Market 2012-2017, by Region, in USD Million
Table Global Oncology Biosimilars Market 2012-2017, by Region, in Volume
Table Oncology Biosimilars Market Forecast 2018-2023, by Region, in USD Million
Table Oncology Biosimilars Market Forecast 2018-2023, by Region, in Volume
Table Global Oncology Biosimilars Market 2012-2017, by Type, in USD Million
Table Global Oncology Biosimilars Market 2012-2017, by Type, in Volume
Table Global Oncology Biosimilars Market Forecast 2018-2023, by Type, in USD Million
Table Global Oncology Biosimilars Market Forecast 2018-2023, by Type, in Volume
Table Celltrion Inc. Overview List
Table Oncology Biosimilars Business Operation of Celltrion Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Oncology Biosimilars Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Oncology Biosimilars Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BIOCAD Overview List
Table Oncology Biosimilars Business Operation of BIOCAD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Overview List
Table Oncology Biosimilars Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Overview List
Table Oncology Biosimilars Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz International GmbH Overview List
Table Oncology Biosimilars Business Operation of Sandoz International GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Ltd. Overview List
Table Oncology Biosimilars Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table STADA Arzneimittel AG Overview List
Table Oncology Biosimilars Business Operation of STADA Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Oncology Biosimilars Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Oncology Biosimilars Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Oncology Biosimilars Sales Revenue Share, by Companies, in USD Million
Table Global Oncology Biosimilars Sales Volume 2012-2017, by Companies, in Volume
Table Global Oncology Biosimilars Sales Revenue Share, by Companies in 2017, in Volume
Table Oncology Biosimilars Demand 2012-2017, by Application, in USD Million
Table Oncology Biosimilars Demand 2012-2017, by Application, in Volume
Table Oncology Biosimilars Demand Forecast 2018-2023, by Application, in USD Million
Table Oncology Biosimilars Demand Forecast 2018-2023, by Application, in Volume
Table Global Oncology Biosimilars Market 2012-2017, by Region, in USD Million
Table Global Oncology Biosimilars Market 2012-2017, by Region, in Volume
Table Oncology Biosimilars Market Forecast 2018-2023, by Region, in USD Million
Table Oncology Biosimilars Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Oncology Biosimilars Industry Chain Structure
Figure Global Oncology Biosimilars Market Growth 2012-2017, by Type, in USD Million
Figure Global Oncology Biosimilars Market Growth 2012-2017, by Type, in Volume
Figure Global Oncology Biosimilars Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Oncology Biosimilars Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Oncology Biosimilars Industry Chain Structure
Figure Global Oncology Biosimilars Market Growth 2012-2017, by Type, in USD Million
Figure Global Oncology Biosimilars Market Growth 2012-2017, by Type, in Volume
Figure Global Oncology Biosimilars Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Oncology Biosimilars Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region